|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS10337|
The global contraceptives market is growing significantly due to increasing incidences of unwanted pregnancies, increasing prevalence of sexually transmitted diseases and advances in contraception techniques. In addition, government and non-government organizations are funding and supporting programs to encourage contraception. Large unexplored contraceptives market in emerging economies is creating ample opportunities for the global contraceptives market to grow at a considerable rate in the coming years. Several major players in the contraception market are actively involved in the research and new product development for contraception, which could meet the demand of cost effective long term contraception.
Contraception is a method used to prevent pregnancy. Several contraceptives, such as hormonal drugs, physical barriers, and advanced contraceptive devices have been developed in order to prevent unwanted pregnancy. Contraceptives also help in preventing sexually transmitted infections. According to a report published by Guttmacher Institute, a non-profit organization working in advance sexual and reproductive health, 213.4 million pregnancies occurred across the globe in 2012, of which 40.0% were unintended. Also, high number of sexually transmitted infection is a major concern across the globe. According to the WHO, in 2013, 35.0 million people lived with HIV/AIDS and 1.5 million people died due to AIDS –related illness worldwide. The organization also reported that an estimated 500 million new curable sexually transmitted infections (including chlamydia, gonorrhoea, syphilis and trichomoniasis only) occur across the globe each year. .
The global contraceptives market is categorized as devices and drugs. Based on devices, the contraceptives market is categorized as contraceptive sponges, vaginal rings, contraceptive diaphragms, intrauterine devices (IUDs), subdermal implants, male condoms, female condoms, and others. The IUDs segment is further categorized as hormonal IUDs and copper IUDs. On the basis of drugs, the contraceptive market can be categorized as topical contraceptives, injectable contraceptives, and oral contraceptives or pills. Contraceptive pills lead the global contraceptive drugs market due to its convenience in use and high efficiency in emergency contraception.
Some of the factors driving the growth of the global contraceptives market are increasing prevalence of sexually transmitted diseases, high number of unwanted pregnancies and continuous advances in contraceptive technology. On the other hand, aging population, increasing infertility rate, and side effects of oral contraceptive drugs are some of the factors restraining the growth of the global contraceptives market to some extent.
Geographically, North America leads the global contraceptives market due to high awareness about contraception, high number of unwanted pregnancies, and increasing prevalence of sexually transmitted diseases among adolescents and young adults. In addition, inclusion of contraception in Patient Protection and Affordable Care Act as preventive services to be provided without co-payment by patient further drives the growth of global contraceptives market in North America region. Asia-Pacific is the fastest growing region in the global contraceptives market. The major reasons for the fastest growth in the region are increasing prevalence of sexually transmitted diseases, high unintended pregnancies, and improving healthcare infrastructure. Moreover, the contraceptives market is growing rapidly due to the several government supported programs for promoting contraception in emerging economies, such as India and China, of Asia-Pacific region.
Some of the major players operating in the global Contraceptives market are Cooper Surgical Inc., Mayer Laboratories Inc., Merck & Co. Inc., Bayer AG, Actavis Inc., Reckitt Benckiser plc, Pfizer Inc., The Female Health Company, Church & Dwight Co., Inc., and Teva Pharmaceutical Industries Ltd.